About Nark Pharmaceuticals Private Limited
Data last updated:
Nark Pharmaceuticals Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 08 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2010PTC027169. Its GSTIN is 32AADCN4701D1Z5 (Kerala).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹53 Lakh. It is led by directors including Navakumar Narayanan (Managing Director) and Ritika Anil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 28/1270 Kezhupilly Cross Road Kadavanthra, Ernakulam, Kerala, India – 682020.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.64 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹4.92 Lakh (net margin 1.9%) and EBITDA of ₹8.46 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nark Pharmaceuticals. As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website narkpharmaceuticals.com.
Company details
Contact details
Nark Pharmaceuticals Private Limited's registered office is in Ernakulam, Kerala. Its website is narkpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address28/1270 Kezhupilly Cross Road Kadavanthra, Ernakulam, Kerala, India – 682020
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Nark Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nark Pharmaceuticals operates one associated brand: Nark Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical medicines in various therapeutic segments. | narkpharmaceuticals.com |
Business activity
The main business activity of Nark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nark Pharmaceuticals Private Limited, buy the company report.
Financials of Nark Pharmaceuticals Private Limited
FY 2025 filings availableNark Pharmaceuticals Private Limited reported revenue of ₹2.64 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 3% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nark Pharmaceuticals Private Limited
Nark Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritika Anil Kumar | Director | 27 Sep 2018 | 8 Years 1 Months | Current |
| Navakumar Narayanan | Managing Director | 08 Dec 2010 | 15 Years 10 Months | Current |
| Sudhakara Reddy Dodla | Director | 20 Jul 2018 | 8 Years 3 Months | Current |
Peer comparison
Nark Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gleveztar Lifesciences Private Limited | ₹2.64 Cr (FY 2025) | 504.0% | Gurgaon, Haryana, India | |||
| Aditus Laboratories Limited | ₹2.64 Cr (FY 2025) | 112.0% | Hyderabad, Telangana, India | |||
| Nark Pharmaceuticals Private Limitedthis company | ₹2.64 Cr (FY 2025) | ₹4.92 Lakh | 1.9% | 3.0% | Ernakulam, Kerala, India | |
| Bee Lifecare Private Limited | ₹2.62 Cr (FY 2018) | -11.0% | Chandigarh, India |
To see the full peer comparison of Nark Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Nark Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nark Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Dec 2018 | 100232579 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Nark Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Court case (CMA(TM)) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
To see the full case history of Nark Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nark Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AADCN4701D1Z5 | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nark Pharmaceuticals Private Limited has 8 board changes on record since 2010: 3 appointments and 5 cessations. The latest: Ritika Anil Kumar ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Nark Pharmaceuticals is an active private limited company based in Ernakulam, Kerala, India. The company works in wholesale, within the trading industry. It was incorporated on 08 December 2010 (16+ years old) and is registered under CIN U51397KL2010PTC027169.
Nark Pharmaceuticals has 3 current directors:
- Navakumar Narayanan - Managing Director
- Ritika Anil Kumar - Director
- Sudhakara Reddy Dodla - Director
The latest financial statements of Nark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nark Pharmaceuticals is 32AADCN4701D1Z5, registered in Kerala.
The CIN (Corporate Identification Number) of Nark Pharmaceuticals is U51397KL2010PTC027169. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nark Pharmaceuticals has 2 court cases on record: 2 filed against it.
Nark Pharmaceuticals was incorporated on 08 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Nark Pharmaceuticals by revenue are Gleveztar Lifesciences Private Limited, Aditus Laboratories Limited, Bee Lifecare Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ritika Anil Kumar ceased to be Additional Director on 30 Sep 2019. Ritika Anil Kumar was appointed as Director on 27 Sep 2018. Madhvendra Puri Das ceased to be Additional Director on 26 Sep 2018. Nark Pharmaceuticals has 8 board changes on record in total.
Nark Pharmaceuticals can be reached through the website narkpharmaceuticals.com. Its registered office is in Ernakulam, Kerala, India.
The registered office of Nark Pharmaceuticals is at 281270 Kezhupilly Cross Road Kadavanthra, Ernakulam, Kerala, India – 682020.